The roles of intracellular second messengers in interferon-y (IFN-'t)-induced Ia antigen (Ag) expression by astroglia and microglia were examined. Ia Ag on both glia types was induced by IFN-~,. Reagents known to increase intracellular cAMP or activate intracellular protein kinase C (PKC) reduced IFN-3,-induced Ia Ag expression by astroglia. In contrast, increasing intracellular cAMP had no suppressive effect on Ia Ag expression by microglia. These results indicate (1) cAMP and PKC negatively regulate IFN-3,-induced Ia expression on astroglia, and (2) Ia expression is regulated differentially in astroglia vs. microglia. These findings may explain the frequent observation of Ia ÷ microglia (or macrophages) but not astroglia in various neurodegenerative diseases.
Introduction
Class II major histocompatibility complex (MHC) antigens (Ag) (also know as Immune response associated Ia Ag) are cell surface molecules that play major roles in regulating immune responses (Kaufman et al., 1984) . Although the brain has traditionally been considered an immunologically privileged site, immune responses have been shown to occur in the central nervous system (CNS) . An effective immune response to an infectious agent or an altered immune response to auto-antigens in the CNS presumably requires the expression of Ia Ag on brain cells (Watanabe et al., 1983; Sobel et al., 1984; Olsson et al., 1987) . In accord with this, in vitro studies indicate that Ia Ag can be induced on distinct populations of brain cells such as microglia, astroglia, and endothelial cells (Wong et al., 1985; Frei et al., 1987; Male et al., 1987; Suzumura et al., 1987) . Interferon-~, (IFN-y) is the most potent inducer of Ia Ag on these cells (McCarron et al., 1986; , although other substances including viruses are known to affect Ia Ag expression on rat astroglia . In vivo, la Ag + microglia have been observed in a large number of neurodegenerative diseases (Hayashi et al., 1988; McGeer et al., 1988) ; in contrast, the description of Ia Ag + astroglia in vivo has been rarer. In situ, immunohistochemical studies have shown that astroglia in active chronic lesions of multiple sclerosis (MS) are positive for Ia Ag (Traugott et al., 1985; Traugott and Lebon, 1988) . However, other MS samples did not have this characteristic  for review, see Hayashi et al., 1988) . These observations suggest that astroglia may regulate Ia Ag differently from microglia.
IFN-T is a species-specific protein that exerts potent biological activities by binding to its specific cell surface receptor (Aguet and Mogensen, 1983; Zoon and Arnheiter, 1984) . Although the precise mechanism of IFN-,/'s action is poorly understood, several reports have suggested that the second messengers generated after IFN-T binds to its surface receptor are responsible for its effects (Hamilton et al., 1985; Celada and Schreiber, 1986; Gariglio et al., 1988) . A collection of previous studies suggest that the intracellular signals utilized by IFN--/ in the induction of Ia Ag might vary from cell type to cell type Koide et al., 1988) . Hence, in some cell types protein kinase C (PKC) activation appears to play a role in the induction of Ia Ag expression, while in other cells PKC is not involved. So far, the intracellular signalling molecules involved in IFN-T-induced Ia Ag expression on brain cells are unknown. This is pertinent considering (1) the importance of Ia Ag in normal and aberrant immune responses in the CNS, and (2) the wealth of CNS mediators that can alter secondary messenger levels and potentially alter the status of Ia Ag expression or nonexpression by glial cells.
Despite the presence of activated T cells and their associated lymphokines in the CNS (Naparstek et al., 1983) only rare Ia Ag-bearing cells have been observed in brains without obvious disease manifestations (Ting et al., 1981; Hauser et al., 1983) . In neurodegenerative disease states, reports of Ia Ag + microglia or macrophages are significantly more frequent and consistent than Ia Ag + astroglia. This paucity of Ia Ag on astroglia in situ led to the hypothesis that astroglial Ia expression may be down-regulated by endogeneous CNS mediators (Frohman et al., 1988a, b) . Many studies have demonstrated that glia are exposed to and respond to neurotransmitter-like substances released from neurons (Koda and Bloom, 1977; Ariano et al., 1982) . Recently, norepinephrine (NE) and vasoactive intestinal polypeptide (VIP) have been shown to inhibit IFN-T-induced Ia Ag expression on cultured rat astroglia (Frohman et al., 1988a, b) . It has been proposed that the cAMP-dependent pathway is involved in the down-regulation of Ia Ag expression generated by both NE and VIP (Frohman et al., 1988a, b) . The role of secondary messengers on Ia Ag expression by microglia has not been investigated, most probably due to difficulties in obtaining sufficient numbers of these cells for experimentation.
To understand the intracelhilar signals that produce IFN-T-induced Ia Ag expression on glial cells, we have purified cultures of astroglia and ameboid microglia from neonatal rat cerebrum and analyzed the effects of various second messengers on IFN-T-induced Ia Ag expression. The results indicate that IFN-T-induced Ia Ag expression on astroglia can be suppressed by a number of agents that alter intracellular secondary messengers and that microglia are not sensitive to this suppression.
Materials and methods

Primary astroglia and microglia cultures
Lewis or Sprague-Dawley rats (2 days postnatal at the latest) were used for the present study. Mixed glial cell cultures were established from new-born rat cerebrum as described previously (McCarthy and deVellis, 1978) . Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with glucose (0.9%), L-glutamine (2 mM), sodium bicarbonate, penicillin (50 IU/ml), streptomycin (50 /~g/ml) plus fetal calf serum (FCS) (10% v/v, Gibco), and incubated at 37°C in an atmosphere of 5% CO z.
The mixed cell cultures became confluent on approximately day 14, then ameboid microglia and type 1 astroglia were purified by a differential adhesion technique (Sasaki et al., 1989) . For microglial cultures, confluent cultures were gently shaken and floating cells were removed. Isolated ameboid microglia were seeded at a density of 5 x l0 s cells/well in 12-well plates (Costar, Cambridge, MA, U.S.A.) and cultured in supple-mented DMEM containing 10% FCS. Ameboid microglia were identified as rat CR3-positive, glial fibrillary acidic protein (GFAP)-negative cells using indirect immunofluorescence techniques (Giulian and Baker, 1986; Robinson et al., 1986; Sasaki et al., 1989) (Fig. 1) . The purity of this population was > 90%. Type 1 astroglia, which C D E remained adherent to the culture dish after overnight shaking, were harvested with trypsin. The astroglia were plated at a density of 2 × 104 cells/cm 2 in 25-cm 2 flasks (Coming, Coming, NY, U.S.A.) and cultured under the conditions described above. Purity of the cells, as determined by GFAP immunohistochemistry, was > 90% (Fig.  1 ). Both cell types were used within 5 days of purification.
Culture additives
A stock solution of rat recombinant IFN-'y (Amgen, Thousand Oaks, CA, U.S.A.) was made in phosphate-buffered saline (PBS) at 2 x 10 4 U/ml. All other chemicals were obtained from Sigma Chemical Co., St. Louis, MO, U.S.A. Phorbol 12-myristate 13-acetate (PMA) and Ca 2+ ionophore A23187 were dissolved in dimethyl sulfoxide (DMSO). 4a-Phorbol and forskolin were prepared in 95% ethanol. 1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine (H7) and N-(6aminohexyl)-5-chloro-l-naphthalenesulfonamide (W7) were dissolved in PBS. Aliquots were stored at -20°C or -70°C to avoid repeated thawing and freezing as much as possible. N6,OZ-dibutyryl-adenosine 3',5'-cyclic monophosphate (DBcAMP), N6,O2-dibutyryl-guanosine 3',5'cyclic monophosphate (DBcGMP), and (-)-isoproterenol (IPT) were diluted in the culture media immediately before use.
Antibodies
A monoclonal mouse IgG1 antibody with reactivity against a monomorphic determinant of rat Ia Ag (MRC OX-6) and a monoclonal IgG2a antibody against rat CR3 (MRC OX-42) were obtained from Serotec, Oxford, U.K. Rabbit anticow GFAP was purchased from Dakopatts, Denmark. Fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG, FITC-conjugated goat anti-rabbit IgG and tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat antimouse IgG were purchased from Cappel (West Chester, PA, U.S.A.) and used as secondary reagents.
Flow cytometry
Astrocytes were prepared as described above followed by an incubation with trypsin (0.25%), and by two washes with media. Microglia were prepared as described and the cells harvested by gentle scraping with the rubber plunger of a 5 or 10 ml plastic syringe. For analysis, 105 -10 6 cells from each treatment were incubated for 45-60 min with MRC OX-6 mAb diluted at 1:100. Bound antibodies were detected by a further 30 min incubation in goat anti-mouse IgG conjugated to FITC (1:20). All incubations were done at 4°C, and all dilutions and washes were in cold Hanks' balanced salt solution (HBSS) with 0.1% bovine serum albumin (BSA) and 0.1% sodium azide. Immediately after staining, labelled cell populations were analyzed on an Ortho CytoFluorograf system 50H (Ortho Diagnostics Systems, Raritan, N J, U.S.A.) or Coulter EPICS V System (Coulter Electronics, Hialeah, FL, U.S.A.). As described before, astroglia and microglia, respectively, expressed no or little (-2%) Ia Ag in the absence of IFN-y treatment (Sasaki et ai., 1989) . This background level of Ia Ag for untreated cultures was subtracted from all experimental values to obtain the percentage of cells that became Ia Ag + after treatment.
Results
PKC reduced 1FN-y-induced Ia Ag expression by astroglia
Astroglia and microglia (discussed below) were prepared by a differential adhesion method as discussed in Materials and Methods (Sasaki et al., 1989) . Astroglia were identified by positive staining with GFAP, and microglia by staining with CR3 but not GFAP. Ia Ag expression on astroglia was analyzed following a single treatment with a number of reagents (Table 1) . The results are summarized in Table 1 . The reagents which caused no changes in Ia expression will not be further discussed. Reagents that inhibited IFN-7-induced Ia expression will be discussed in detail later (in Tables 2-4). As described previously by us and others, treatment with 50 U/ml of IFN-y alone for 2 days induced Ia Ag expression on approximately 50% of the astroglia. As early as 24 h after exposure to IFN-y, Ia Ag was detectable by flow cytometry and approximately 35% of the cells were Ia Ag ÷ (data not shown). Astroglia treated with all other substances at various concentrations for various incubation times (3 h to 5 days) showed no Ia Ag induction. Combined treatment with PMA (10 ng/ml) plus A23187 (0.2/tM) for 2 days did not induce Ia Ag. Astroglia treated with DBcAMP, forskolin, IPT, or H7 often changed their cell morphology from flat cells to stellate cells (data not shown). However, their viability was not affected as determined by trypan blue exclusion.
To determine if cAMP or PKC are second messengers involved in the IFN-7 response, astroglial cultures were cotreated with IFN-~, and reagents known to affect secondary messengers for 2 days (Table 1 ). Simultaneous treatment of astroglia with IFN-y (50 U/ml) and PMA (1-1000 nM) produced a dose-dependent inhibition of Ia Ag expression ranging from 7% at 1 nM of PMA to 56% at 1000 nM (Fig. 2) . 4a-Phorbol (1-1000 nM), an inactive phorbol that has no effect on PKC also had no effect on IFN-y-induced Ia Ag expression.
The suppressive effect of PMA on IFN-y-induced la Ag expression by astroglia is associated with PKC activation
PMA is known to stimulate PKC in a manner similar to diacylglycerol and elicits many of the physiologic effects of this enzyme. Several controls were used to determine if the suppressive effects of PMA could be attributed to PKC activation. First, preincubation of cells with PMA is known to initiate the degradation of PKC and its sustained disappearance from cells (Young et al., 1987; Ase et al., 1988) . Prolonged pretreatment (1 day) with a high dose of PMA (1 #M) is the standard protocol used to deplete PKC in various cells. Such pretreatment did not suppress the IFN-3,-induced expression of Ia, and actually slightly increased Ia Ag expression on astroglia (Table 2) . Conversely, IFN-y-induced Ia Ag expression on astroglia was suppressed by pretreatment with PMA for a short time (10 min to 1 h). Secondly, the effect of H7, a potent and selective inhibitor of PKC was also tested (Hidaka et al., 1984) . Pre- treatment with H7 (20 ~M) for 1 h prior to the addition of IFN-y did not inhibit Ia Ag expression on astroglia (Table 3~ . Neither was an inhibition of IFN-v-induced Ia Ag expression observed after longer pretreatment with H7 (10/~M, 3 h). On the contrary, H7 reversed the suppressive effect of PMA on Ia Ag induction. Collectively these resuits suggest that PKC activation is not necessary for IFN-~/-induced Ia Ag expression on astroglia and that PKC activation actually reduced IFN-7induced Ia Ag induction.
Cycfic AMP reduced IFN-T-induced la Ag expression by astroglia
The cotreatment of astroglia with IFN-T and 100-1000 #M DBcAMP, 10-100 #M forskolin or 1-100/~M IPT produced a dose-dependent inhibition of Ia Ag expression which ranged from 25 to 69%, 34 to 44% or 35 to 45%, respectively (Table  4 ). All these reagents are known to increase intracellular cAMP in primary astroglia. Therefore, these results strongly suggest that cAMP can suppress IFN-T-induced Ia Ag expression on astroglia as reported previously (Frohman et al., 1988a) . Simultaneous treatment with DBcAMP (1 mM) and PMA (100 nM) almost abolished the IFN-Tinduced Ia Ag expression ( Fig. 3) . These results imply that PKC activation and increased cAMP can inhibit IFN-T-induced Ia Ag expression. Various concentrations of other substances such as the calcium ionophore A23187, the calmodulin antagonist W7 (Hidaka et al., 1981) , and DBcGMP did not inhibit or augment IFN-T-induced Ia Ag expression (Table 1) .
IFN-T-induced la Ag expression by microglia was not affected by cAMP
Our previous report showed that IFN-T induced Ia Ag expression on ameboid microglia The percent Ia Ag + cells were always a little higher than that of IFN-T alone: -16% for DBcAMP-treated cells, 7% for forskolin and 13% for IPT. 219 more readily than astroglia (Sasaki et al., 1989) .
To determine if the IFN-T-induced expression of Ia Ag on ameboid microglia and astroglia were regulated similarly, microglia were treated with analogs of second messengers or inducers of second messengers and analyzed for Ia Ag expression (Table 5 ). In contrast to astroglia, forskolin (10 /~M), IPT (10 #M) or DBcAMP (100 #M) did not suppress IFN-T-induced Ia Ag expression on microglia. This suggests that increased cAMP has little suppressive effect on IFN-T-induced Ia Ag expression by ameboid microglia. Treatment with PMA (100 nM) induced many microglia to alter their morphology to giant cells or to die, therefore, we could not analyze the effects of PMA on IFN-T-induced Ia Ag expression by microglia.
Discussion
The two novel observations in this report are (1) PKC activation suppresses the IFN-T-induced Ia Ag expression by astroglia, and (2) the elevation of intracellular cAMP selectively suppresses IFN-T-induced Ia Ag expression by astroglia but not ameboid microglia. The findings with astroglia imply that two major signal-transducing molecules, cAMP-dependent protein kinase (PKA) and PKC, act as negative regulatory signals of the IFN-T-induced Ia Ag expression on these cells. In fact, simultaneous activation of both PKA and PKC abrogated Ia Ag expression (90% suppression of Ia Ag expression).
Negative effects of PKC on IFN-T-induced Ia Ag expression by astroglia have not been previously reported. A priori, PKC would appear to be a likely signalling molecule for astroglia based on the following findings: (1) the receptor-linked inositol lipid pathway can be activated in astroglia (Girard et al., 1985; Mochley-Rosen et al., 1987) , and (2) astroglia are rich in immunoreactive PKC (Pearce et al., 1986; Ritchie et al., 1987) . In fact, one report showed that PMA per se could induce Ia Ag expression on rat astroglia (Frohman et al., 1988a) . We extensively investigated the role of PKC in Ia Ag induction using a combination of PMA, an inactive phorbol ester 4a-phorbol, and an inhibitor of PKC, H7. Our results demonstrate that (1) PKC activation does not appear to be involved in the positive regulation of astroglial Ia Ag by IFN-y because H7 does not affect this process, (2) PMA does not induce Ia Ag even in the presence of A23187, and (3) most interestingly, PKC activation can actually inhibit IFN-7induced Ia Ag expression by astroglia. This is in contrast to the observation of Massa et al. (1987b) that both PMA and Ca ionophore A23187 induced Ia Ag expression on rat astroglia. However, in their study Ia Ag induction by these inducers seems to occur at a narrow concentration and specific treatment interval (for example, only at 10 ng/ml of PMA for 5 days). We duplicated their treatment protocol and still did not observe any Ia Ag induction. The reason for this discrepancy is not clear.
The effect of cAMP on Ia Ag induction was investigated by the administration of DBcAMP (cAMP analogue), forskolin (activator of adenylate cyclase) or IPT (/3-adrenergic receptor agonist).
Our results show that all treatments examined which increased intracellular cAMP levels in astroglia inhibited IFN-7-induced Ia Ag expression in a dose-dependent manner. This data is compatible with a report by Frohman et al. (1988a) .
This analysis did not reveal the nature of second messengers utilized by IFN-7 in inducing Ia Ag expression on cultured astroglia. A study of the human promyelocytic monocytic line U937 suggested that PKC might be a positive regulator of IFN-7-induced Ia Ag expression because the inhibition of PKC suppressed the IFN-y effect. This is not the case with astroglia. These divergent findings suggest that different intracellular signals generated by IFN-7 may regulate Ia Ag in astroglia versus U937 Koide et al., 1988) . A recent study has shown that sodium and intracellular pH are involved in IFN--/-induced Ia Ag expression in primary macrophages (Prpic et al., 1989) . It is of interest sodium in IFN-7-induced astroglia.
This study supports the to examine the role of Ia Ag expression on hypotheses that activation of PKC and/or PKA down-regulates IFN-7induced Ia Ag expression on rat astroglia, and that Ia Ag expression on astroglia is subject to negative control (Frohman et al., 1988b) . Compatible with these hypotheses, a number of studies indicate that cultured astroglia express receptors that regulate phosphatidylinositol metabolism, which activate PKC (Pearce et al., 1985; De George et al., 1986) . Astroglia also express the /3-adrenergic and a-adrenergic receptors for norepinephrine, which increase cAMP and diacylglycerol levels. Many endogenous brain substances are able to modulate cAMP or PI metabolism via surface receptors and these may suppress the expression of Ia Ag on astroglia. Further studies, including transcriptional and translational analyses, must be carried out to understand the mechanism of negative control of Ia Ag expression on astroglia. A preliminary Northern hybridization analysis indicates that IFN-7 induction and DBcAMP inhibition are both regulated at the transcriptional level (unpublished data).
Recent reports have suggested that microglia may play important roles as the major CNS cell type that expresses la Ag and participates in immune processes (Matsumoto et al., 1986; Hayes et al., 1987; McGeer et al., 1988) . In accord with this, our previous report showed that IFN-7 induced greater numbers of Ia Ag-expressing microglia than astroglia (Sasaki et al., 1989) . To further examine the regulation and expression of Ia Ag on microglia this study showed that in contrast to astroglia, forskolin, IPT or DBcAMP did not affect Ia Ag expression by microglia. The regulation of Ia Ag on microglia also may be different from macrophages since a previous report indicates that cAMP inhibits the induction of macrophage Ia Ag expression (Steeg et al., 1982) . This discrepancy may be due to the different assays used in the two studies, or a more interesting explanation is that ameboid microglia constitute a distinct class of tissue macrophages.
The differential sensitivity of microglia and astroglia to cAMP suppression is intriguing. In vitro both microglia and astroglia can be induced to express Ia Ag by IFN-7 and can function as APC . However, in vivo immunohistochemical studies of brain tissues indicate that most Ia Ag-expressing cells in disease states are most likely microglia. This is true for rat experimental allergic encephalomyelitis (Hickey et al., 1985; Matsumoto et al., 1986) and a large number of human neurological diseases (McGeer et al., 1988) . As a cautionary note, however, microgliaspecific markers need to be used in such studies to distinguish microglia from blood-derived macrophages. Conversely, the observation of Ia Ag ÷ astroglia in brain tissue sections is rare. This study presents a potential basis for the differential expression of Ia Ag by microglia and astroglia. The predominance of Ia Ag + microglia in neurologic disease is in accord with our results revealing their sensitivity to IFN-~, as a positive regulator of Ia Ag, and their insensitivity to increased intracellulax cAMP levels as a negative regulator of Ia Ag.
The differential regulation of Ia Ag on astroglia and rnicroglia is in accord with molecular biologic studies performed in the laboratory. Analysis of an octamer DNA element that is critical for HLA-DRA gene expression has shown that this element is only critical for HLA-DRA gene expression in B cells but not in non-B cells, including a glioblastoma multiforme. The function of this dement in B cell is achieved through DNA-protein interactions most likely via complex formation with a B cell-specific DNA binding protein (Sherman et al., 1989) .
